Focus:

Cancer Channel Featured Story TOP

Add to Favorites Subscribe Share
fbshare-Cancer Channel Featured Story TOP

Showing results

110 of 100
Horizontal-CHLA-Logo.png

Article ID: 719042

First Positive Results in 45 Years: Rhabdomyosarcoma Randomized Clinical Trial Led by Children’s Hospital Los Angeles

Children's Hospital Los Angeles

A randomized clinical trial led at Children's Hospital Los Angeles by Leo Mascarenhas, MD, MS, showed first positive results in rhabdomyosarcoma since 1974.

Released:
17-Sep-2019 8:00 AM EDT
Newswise: Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Article ID: 718812

Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Johns Hopkins Medicine

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings. Now, researchers at Johns Hopkins Medicine have improved on this protein and shown that it selectively kills cells that cause the hardening of skin associated with scleroderma, effectively reversing the condition in mice genetically engineered to mimic the disease. A report on these results was published earlier this year in Nature Communications.

Released:
12-Sep-2019 9:00 AM EDT
Newswise: 2019 Gynecologic Cancer Survivorship Conference: Thriving Through Education and Connection

Article ID: 718431

2019 Gynecologic Cancer Survivorship Conference: Thriving Through Education and Connection

Johns Hopkins Medicine

A premier educational event sponsored by the Johns Hopkins Kelly Gynecologic Oncology Service and the Division of Gynecologic Oncology at Sibley Memorial Hospital, this one-day conference gathers more than 25 experts to provide cancer survivors and their caregivers

Released:
5-Sep-2019 9:00 AM EDT

Article ID: 718182

Birmingham Woman Meets Philadelphia Man Who Saved Her Life Through Bone Marrow Donation

Children's of Alabama

Jada Lucas, a 22-year-old bone marrow recipient from Birmingham, met the bone marrow donor who helped save her life — Jerome Lewis of Philadelphia, Penn. — at donor registry event at Children's of Alabama.

Released:
28-Aug-2019 3:05 PM EDT
Newswise: Will Disposable Colonoscopy Devices Replace Reusables?

Article ID: 717929

Will Disposable Colonoscopy Devices Replace Reusables?

Johns Hopkins Medicine

As a disposable version of the instrument used in one of the most common medical procedures in the United States inches closer to widespread availability, a team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies.

Released:
26-Aug-2019 9:00 AM EDT
  • Embargo expired:
    21-Aug-2019 5:00 PM EDT

Article ID: 717580

Unprecedented Therapy Found Effective for Blood Cancer Patients With No Treatment Options

Mount Sinai Health System

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

Released:
16-Aug-2019 11:00 AM EDT
Newswise: Antibiotics Exposure Linked to Increased Colon Cancer Risk

Article ID: 717661

Antibiotics Exposure Linked to Increased Colon Cancer Risk

Johns Hopkins Medicine

In an extensive “data mining” analysis of British medical records, researchers at the Johns Hopkins Kimmel Cancer Center conclude that taking even a single course of antibiotics might boost—albeit slightly—the risk of developing colon cancer—but not rectal cancer—a decade later. The findings, reported in the August 20 issue of the journal Gut, highlight the need for judicious use of this broad category of drugs, which are frequently improperly or overprescribed, the report authors say.

Released:
21-Aug-2019 9:00 AM EDT
Newswise: CWRU School of Nursing Awarded $2.14M National Cancer Institute Grant

Article ID: 717595

CWRU School of Nursing Awarded $2.14M National Cancer Institute Grant

Case Western Reserve University

With a $2.14 million grant from the National Cancer Institute (NCI), researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University will measure whether an approach that uses simulation or experiential learning can affectively teach family caregivers not only the skills to take better care of their patient, but better care of their own emotional and physical health amid such incredible stress.

Released:
19-Aug-2019 10:00 AM EDT
Newswise: Henry Ford Cancer Institute Enrolls First Patient in World’s Largest Brain Cancer Clinical Trial

Article ID: 717461

Henry Ford Cancer Institute Enrolls First Patient in World’s Largest Brain Cancer Clinical Trial

Henry Ford Health System

A next-generation clinical trial program and the first-ever adaptive platform trial for brain cancer, GBM AGILE is a move away from the traditional, one-size-fits-all approach to clinical trials – a major step forward for Precision Medicine.

Released:
14-Aug-2019 11:05 AM EDT
Newswise: Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients
  • Embargo expired:
    11-Jul-2019 11:00 AM EDT

Article ID: 715470

Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients

Perelman School of Medicine at the University of Pennsylvania

Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they’ve completed locally ablative therapy almost tripled the median progression-free survival compared to the historical average.

Released:
9-Jul-2019 11:00 AM EDT

Showing results

110 of 100

Chat now!